CETRINE Film-coated tablet Ref.[50661] Active ingredients: Cetirizine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2019  Publisher: Rowex Ltd, Bantry, Co. Cork, Ireland

4.1. Therapeutic indications

Cetrine is indicated in adults and paediatric patients 6 years and above:

  • for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis.
  • for the relief of symptoms of chronic idiopathic urticaria.

4.2. Posology and method of administration

Posology

Children aged from 6 to 12 years

5mg twice daily (a half a tablet twice daily).

Adults and adolescents over 12 years of age

10 mg once daily (1 tablet).

Elderly patients

Data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal.

Patients with moderate to severe renal impairment

There are no data to document the efficacy/safety ratio in patients with renal impairment. Since cetirizine is mainly excreted via renal route (see section 5.2), in cases no alternative treatment can be used, the dosing intervals must be individualised according to renal function. Refer to the following table and adjust the dose as indicated. To use the dosing table an estimate of the patient’s creatinine clearance (CLcr) in ml/min is needed. The CLcr (ml/min) may be estimated from serum creatinine (mg/dl) determination using the following formula;

CLcr = [140 – age (years)] x weight (kg) / 72 x serum creatinine (mg/dl)

(x 0.85 for women)

Dosing adjustments for adult patients with impaired renal function:

Group Creatinine Clearance (ml/min) Dosage and frequency
Normal≥80 10mg once daily
Mild 50 – 79 10mg once daily
Moderate 30 – 49 5mg once daily
Severe<30 5 mg once every 2 days
End Stage Renal Disease –
Patients undergoing dialysis
<10 Contraindicated

In paediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance of the patient and the body weight.

Patients with hepatic impairment

No dose adjustment is needed in patients with solely hepatic impairment.

Patients with hepatic impairment and renal impairment

Dose adjustment is recommended (see Patients with moderate to severe renal impairment above).

Method of administration

The tablets need to be swallowed with a glass of liquid.

4.9. Overdose

a) Symptoms

Symptoms observed after an overdose of cetirizine are mainly associated with CNS effects or with effects that could suggest an anticholinergic effect.

Adverse events reported after an intake of at least 5 times the recommended daily dose are: confusion, diarrhoea, dizziness, fatigue, headache, malaise, mydriasis, pruritus, restlessness, sedation, somnolence, stupor, tachycardia, tremor, and urinary retention.

b) Management

There is no known specific antidote to cetirizine.

Should overdose occur, symptomatic or supportive treatment is recommended. Gastric lavage should be considered following ingestion of the medicinal product.

Cetirizine is not effectively removed by haemodialysis.

6.3. Shelf life

3 years.

6.4. Special precautions for storage

Do not store above 25°C.

6.5. Nature and contents of container

Cetrine 10 mg tablets are packed into PVC/Al strips and inserted into a carton.

Cetrine 10 mg tablets are available in packs of 30 tablets.

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

Not applicable.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.